AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma

Affiliations

¹ Division of Gastroenterology , University of California Davis Health , Sacramento , California , USA.
² Hôpital Saint-Antoine , Paris , France.
³ Karolinska Institutet , Karolinska University Hospital , Stockholm , Sweden.
⁴ University of Utah , Salt Lake City , Utah , USA.
⁵ University of Colorado , Aurora , Colorado , USA.
⁶ Mayo Clinic College of Medicine and Science , Rochester , Minnesota , USA.
⁷ Rutgers University-New Jersey Medical School , Newark , New Jersey , USA.
⁸ Vagelos College of Physicians and Surgeons , Columbia University , New York , New York , USA.
⁹ University of Toronto , Toronto , Ontario , Canada.
¹⁰ University of Arizona , Tucson , Arizona , USA.
¹¹ David Geffen School of Medicine at UCLA , Los Angeles , California , USA.
¹² Yale School of Medicine , New Haven , Connecticut , USA.

Christopher L Bowlus et al. Hepatology. 2023.

. 2023 Feb 1;77(2):659-702.

doi: 10.1002/hep.32771. Epub 2022 Oct 20.

¹ Division of Gastroenterology , University of California Davis Health , Sacramento , California , USA.
² Hôpital Saint-Antoine , Paris , France.
³ Karolinska Institutet , Karolinska University Hospital , Stockholm , Sweden.
⁴ University of Utah , Salt Lake City , Utah , USA.
⁵ University of Colorado , Aurora , Colorado , USA.
⁶ Mayo Clinic College of Medicine and Science , Rochester , Minnesota , USA.
⁷ Rutgers University-New Jersey Medical School , Newark , New Jersey , USA.
⁸ Vagelos College of Physicians and Surgeons , Columbia University , New York , New York , USA.
⁹ University of Toronto , Toronto , Ontario , Canada.
¹⁰ University of Arizona , Tucson , Arizona , USA.
¹¹ David Geffen School of Medicine at UCLA , Los Angeles , California , USA.
¹² Yale School of Medicine , New Haven , Connecticut , USA.

No abstract available

Comment in

Reply: Insurance should cover vancomycin for primary sclerosing cholangitis.
Bowlus CL, Arrivé L, Bergquist A, Deneau M, Forman L, Ilyas SI, Lunsford KE, Martinez M, Sapisochin G, Shroff R, Tabibian JH, Assis DN. Bowlus CL, et al. Hepatology. 2023 Jun 1;77(6):E176-E177. doi: 10.1097/HEP.0000000000000305. Epub 2023 Jan 26. Hepatology. 2023. PMID: 36695291 No abstract available.
Letter to the Editor: Insurance should cover vancomycin for primary sclerosing cholangitis.
Ali AH, Buness CW, Fischer R, Holtmann GJ, Shah A, Lewindon P, Shah S, Ragnekar AS, Taylor AE, Goel A, Cox KL, Alrabadi L, Wadsworth S, Kulkarni SS, Lindor KD. Ali AH, et al. Hepatology. 2023 Jun 1;77(6):E174-E175. doi: 10.1097/HEP.0000000000000304. Epub 2023 Jan 30. Hepatology. 2023. PMID: 36705026 No abstract available.
Reply: Living donor liver transplantation for people with PSC.
Forman LM, Sapisochin G, Assis DN, Arrivé L, Bergquist A, Bowlus CL, Deneau M, Ilyas SI, Lunsford KE, Martinez M, Shroff R, Tabibian JH. Forman LM, et al. Hepatology. 2023 May 1;77(5):E97-E98. doi: 10.1097/HEP.0000000000000210. Epub 2023 Jan 3. Hepatology. 2023. PMID: 36732294 No abstract available.
Letter to the Editor: Living donor liver transplantation for people with PSC.
Heinemann M, Adam R, Karam V, Schramm C. Heinemann M, et al. Hepatology. 2023 May 1;77(5):E95-E96. doi: 10.1097/HEP.0000000000000208. Epub 2023 Jan 3. Hepatology. 2023. PMID: 36735268 No abstract available.

1. Bambha K, Kim WR, Talwalkar J, Torgerson H, Benson JT, Therneau TM, et al. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology. 2003;125:1364–9.
1. Lindkvist B, Benito de Valle M, Gullberg B, Björnsson E. Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in Sweden. Hepatology. 2010;52:571–7.
1. Barner‐Rasmussen N, Pukkala E, Jussila A, Farkkila M. Epidemiology, risk of malignancy and patient survival in primary sclerosing cholangitis: a population‐based study in Finland. Scand J Gastroenterol. 2020;55:74–81.
1. Boonstra K, Beuers U, Ponsioen CY. Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. J Hepatol. 2012;56:1181–8.
1. Card TR, Solaymani‐Dodaran M, West J. Incidence and mortality of primary sclerosing cholangitis in the UK: a population‐based cohort study. J Hepatol. 2008;48:939–44.